Analytical validation of quality control materials for Huntington’s disease examination
Autor: | John P. Jakupciak, Kristy L. Richie |
---|---|
Rok vydání: | 2007 |
Předmět: |
medicine.medical_specialty
business.industry General Chemical Engineering media_common.quotation_subject Genetic Examination General Chemistry medicine.disease Molecular diagnostics Certified reference materials Huntington's disease medicine Quality (business) Medical physics Personalized medicine Safety Risk Reliability and Quality business Good laboratory practice Instrumentation Quality assurance media_common |
Zdroj: | Accreditation and Quality Assurance. 12:139-145 |
ISSN: | 1432-0517 0949-1775 |
DOI: | 10.1007/s00769-006-0226-5 |
Popis: | The expansion of molecular diagnostics using nucleic acid technologies in clinical and public health practice has increased the need for appropriate reference materials and verified quality-control materials for quality assurance, test validation, proficiency testing and the development of new examination procedures. Good laboratory practice requires the use of reference materials to establish an examination procedure and assess the variability of the results. Reference materials are also required to assess the assay on a daily basis and to normalize results collected among different laboratories. Despite the growing volume, the rapidly increasing number of tests being offered, and the necessary routine use, certified reference materials are often not available. There is a wide range of human genetic bio-assays for which there are no available traceable certified reference materials. Several initiatives have been organized to provide well-characterized quality control specimens (e.g., cell lines) with known DNA mutations for use in diagnostics. Mutations are confirmed with bi-directional DNA sequence analysis, which is considered the reference examination procedure. In the field of personalized medicine, NIST has created and validated Standard Reference Material® 2399 for fragile X examinations. Herein we describe our characterization of candidate reference materials for Huntington’s disease genetic examination. Bi-directional DNA sequencing confirmed the size of the CAG repeat contained on each allele from patient derived materials. Amplification and capillary electrophoresis of the CAG repeats had an uncertainty ranging from 2.06%CV to 7.83%CV. |
Databáze: | OpenAIRE |
Externí odkaz: |